SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: July 29, 1999
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-19266 23-1370721
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification No.)
Incorporation)
1720 Sublette Avenue
St. Louis, MO 63110
(Address of Principal Executive Offices) (Zip Code)
(314) 771-2400
(Registrant's telephone number, including area code)
page 1 of 5
<PAGE>
ITEM 5. OTHER EVENTS.
On July 28, 1999, the Registrant issued a news release announcing that its
president, chief executive officer and a director, Uma Nandan Aggarwal has
resigned to pursue other interests. Chief Financial Officer Thomas A. Jenuleson
will serve as acting CEO of the company until a permanent CEO is selected. The
Registrant's news release, issued on July 28, 1999, is attached as Exhibit 1
hereto, is incorporated herein by reference and made a part hereof.
page 2 of 5
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ALLIED HEALTHCARE PRODUCTS, INC.
Date: July 29, 1999 By: /s/ Thomas A. Jenuleson
-------------------------
Name: Thomas A. Jenuleson
Title: Acting Chief Executive Officer
page 3 of 5
<PAGE>
EXHIBIT INDEX
Exhibit No. Description Page No.
- ------------ ----------- ---------
1. News Release dated July 28, 1999 5
page 4 of 5
<PAGE>
Exhibit 1 - Press Release
FOR IMMEDIATE RELEASE
Contacts: Thomas A. Jenuleson Tom Goyda or Beth Randolph
Chief Financial Officer Shandwick
(800) 444-3954 (314) 436-6565
ALLIED HEALTHCARE PRODUCTS' CEO RESIGNS
ST. LOUIS, July 28, 1999 -- Allied Healthcare Products, Inc. (NASDAQ:AHPI)
announced today that Uma Nandan Aggarwal, its president, chief executive officer
and a director since November 1996, has resigned to pursue other interests. A
search for a new chief executive is underway and the company anticipates that a
successor will be named in the near future.
"Our new CEO will work with our board and management team to address the
challenges facing Allied and return the company to profitability," said John D.
Weil, the company's chairman. "We appreciate what Uma Aggarwal has done to
stabilize Allied's operations and strengthen its balance sheet, and wish him the
best in his future endeavors."
Chief Financial Officer Thomas A. Jenuleson, 53, will serve as acting CEO
of the company until a permanent CEO is selected. Jenuleson joined Allied in
March of this year and had previously been vice president-finance of Metal
Container Corporation, one of the Anheuser-Busch companies.
Allied Healthcare Products, Inc. is a leading manufacturer of respiratory
therapy equipment, medical gas equipment and emergency medical products used in
a wide range of hospital and alternate site settings.
# # #
page 5 of 5
<PAGE>
